June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Inhibition of HIF-1α Downregulates EMT Early Marker Proteins Without Undermining Cell Survival in Hypoxic Lens Epithelial Cells
Author Affiliations & Notes
  • Patrick R Cammarata
    Cell Biology & Immunology, University of North Texas Hlth Sci Ctr, Fort Worth, TX
  • Sudha Neelam
    Cell Biology & Immunology, University of North Texas Hlth Sci Ctr, Fort Worth, TX
  • Morgan M Brooks
    Cell Biology & Immunology, University of North Texas Hlth Sci Ctr, Fort Worth, TX
  • Footnotes
    Commercial Relationships Patrick Cammarata, None; Sudha Neelam, None; Morgan Brooks, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2650. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Patrick R Cammarata, Sudha Neelam, Morgan M Brooks; Inhibition of HIF-1α Downregulates EMT Early Marker Proteins Without Undermining Cell Survival in Hypoxic Lens Epithelial Cells. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2650.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To identify potential therapeutic strategies to slow down or prevent the expression of early-onset epithelial to mesenchymal transition (EMT) marker proteins without sacrificing the pro-survival protein, VEGF, in cultured hypoxic lens epithelial cells.

Methods: HLE-B3 cells, maintained in continuous hypoxic environment (1% oxygen) were treated with SB216763, a specific inhibitor of GSK-3β catalytic activity. Western blot analysis was employed to detect the cytoplasmic and nuclear levels of β-catenin and phospho-β-catenin, as well as the total lysate content of fibronectin and α-smooth muscle actin (α-SMA). ELISA was used to measure the levels of VEGF in cell culture supernatants. A HIF-1α translation inhibitor and a HIF-2α translation inhibitor were independently employed to evaluate the effect of hypoxia inducible factor inhibition on EMT marker protein and VEGF expression. XAV932 was used to assess the suppression of nuclear β-catenin and its downstream effect on EMT marker proteins and VEGF expression.

Results: SB216763-treated HLE-B3 cells caused a marked inhibition of GSK-3β activity prompting a significant increase in the translocation of cytoplasmic β-catenin to the nucleus. The enhancement of nuclear β-catenin resulted in significant increase of basal expression of VEGF as well as increased expression of fibronectin and α-SMA. Administration of a HIF-1α translation inhibitor, but not a HIF-2α translation inhibitor, markedly suppressed expression of fibronectin and α-SMA without affecting VEGF levels. Treatment with XAV932 significantly reduced the level of nuclear β-catenin whereas neither the levels of the EMT marker proteins nor VEGF were changed.

Conclusions: Recently, we reported that nuclear β-catenin but not HIF-2α, regulates the expression of fibronectin and α-SMA in atmospheric oxygen. In marked contrast, data stemming from the hypoxic condition clearly establishes that nuclear β-catenin plays no apparent role in the expression of EMT marker proteins. Rather, it is the loss of HIF-1α (but not HIF-2α), that lowers the expression of the EMT marker proteins without sacrificing the levels of the pro-survival protein, VEGF. These findings support the development of a potentially relevant therapeutic strategy to undermine the progression of normal cells to mesenchymal phenotype in the naturally hypoxic lens without subverting cell viability.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×